Targeting the insulin-like growth factor-1 receptor to overcome bortezomib resistance in preclinical models of multiple myeloma.
暂无分享,去创建一个
Michael L. Wang | R. Davis | V. Baladandayuthapani | D. Kuhn | Caimiao Wei | Wencai Ma | Richard J. Jones | R. Orlowski | T. Madden | P. Lin | Z. Berková | R. Woessner | C. Bjorklund | Hua Wang | Sheeba K. Thomas | J. Shah | D. Weber | S. Thomas